Horm Metab Res
DOI: 10.1055/a-2365-7521
Original Article: Endocrine Care
Fangling Liu
1
Key Laboratory of Analytical Chemistry of the State
Ethnic Affairs Commission, School of Chemistry and Materials Science,
South-Central Minzu University, Wuhan, China (Ringgold ID: RIN12404)
,
Chongxin Kang
1
Key Laboratory of Analytical Chemistry of the State
Ethnic Affairs Commission, School of Chemistry and Materials Science,
South-Central Minzu University, Wuhan, China (Ringgold ID: RIN12404)
,
Zheng Hu
1
Key Laboratory of Analytical Chemistry of the State
Ethnic Affairs Commission, School of Chemistry and Materials Science,
South-Central Minzu University, Wuhan, China (Ringgold ID: RIN12404)
,
Xiaoping Luo
2
Department of Pediatrics, Tongji Hospital, Tongji Medical College,
Huazhong University of Science and Technology, Wuhan, China
,
Wei Wu
2
Department of Pediatrics, Tongji Hospital, Tongji Medical College,
Huazhong University of Science and Technology, Wuhan, China
,
Qiuying Tao
1
Key Laboratory of Analytical Chemistry of the State
Ethnic Affairs Commission, School of Chemistry and Materials Science,
South-Central Minzu University, Wuhan, China (Ringgold ID: RIN12404)
,
Quan Chi
1
Key Laboratory of Analytical Chemistry of the State
Ethnic Affairs Commission, School of Chemistry and Materials Science,
South-Central Minzu University, Wuhan, China (Ringgold ID: RIN12404)
,
Jing Yang
1
Key Laboratory of Analytical Chemistry of the State
Ethnic Affairs Commission, School of Chemistry and Materials Science,
South-Central Minzu University, Wuhan, China (Ringgold ID: RIN12404)
,
Xian Wang
1
Key Laboratory of Analytical Chemistry of the State
Ethnic Affairs Commission, School of Chemistry and Materials Science,
South-Central Minzu University, Wuhan, China (Ringgold ID: RIN12404)
› Author Affiliations
Fundings
National Natural Science Foundation of China | Grant No. 22276221
Fundamental Research Funds for the Central Universities, and
South-Central Minzu University | Grant No. CZP21002
› Further Information
Also available at
![SFX Search]()
Buy Article Permissions and Reprints
Abstract
Congenital adrenal hyperplasia (CAH) manifests as an autosomal recessive disorder
characterized by defects in the enzymes responsible for steroid synthesis. This
work aims to perform metabolic profiling of patients with CAH, screen key
differential metabolites compared to the control group, and discover the
associated metabolic pathways implicated in CAH. Serum samples obtained from 32
pediatric male patients with CAH and 31 healthy control group candidates were
subjected to analysis using non-targeted metabolomics strategy using ultra
performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). A total
of 278 differential metabolites were identified and annotated in KEGG. Operating
characteristic curves (ROC) measurement exhibited 9 metabolites exhibiting high
efficacy in differential diagnosis, as evidenced by an area under ROC curve
(AUC) exceeding 0.85. Pathway analysis uncovered notable disruptions in steroid
hormone biosynthesis (p <0.0001), purine metabolism and irregularities in
lipid metabolism and amino acid metabolism, including tyrosine and alanine, in
CAH patients. These findings demonstrate that metabolic pathways of purine,
amino acid and lipid metabolism, apart from steroid hormone biosynthesis, may be
disrupted and associated with CAH. This study helps provide insight into the
metabolic profile of CAH patients and offers a new perspective for monitoring
and administering follow-up care to CAH patients.
Keywords
congenital adrenal hyperplasia -
untargeted metabolomics -
differential metabolites -
metabolic pathways -
ultra performance liquid chromatography-tandem mass spectrometry
(UPLC-MS/MS)
Publication History
Received: 03 April 2024
Accepted after revision: 03 July 2024
Article published online:
12 August 2024
© 2024. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
References
1
El-Maouche D,
Arlt W,
Merke DP.
Congenital adrenal hyperplasia. Lancet 2017; 390: 2194-2210
2
Lu W,
Zhang T,
Zhang L.
et al.
Clinical characteristics of a male child with non-classic lipoid congenital
adrenal hyperplasia and literature review. Front Endocrinol 2022; 13: 947762
3
Engels M,
Gehrmann K,
Falhammar H.
et al.
Gonadal function in adult male patients with congenital adrenal hyperplasia. Eur J Endocrinol 2018; 178: 285-294
4
Hamed SA,
Metwalley KA,
Farghaly HS.
Cognitive function in children with classic congenital adrenal hyperplasia. Eur J Pediatr 2018; 177: 1633-1640
5
Speiser PW,
Arlt W,
Auchus RJ.
et al.
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an
endocrine society clinical practice guideline. J Clin Endocrinol 2018; 103: 4043-4088
6
Odom JD,
Sutton VR.
Metabolomics in clinical practice: improving diagnosis and informing
management. Clin Chem 2021; 67: 1606-1617
7
Cui L,
Lu HT,
Lee YH.
Challenges and emergent solutions for LC-MS/MS based untargeted metabolomics in
diseases. Mass Spectrom Rev 2018; 37: 772-792
8
Gertsman I,
Barshop BA.
Promises and pitfalls of untargeted metabolomics. J Inherit Metab Dis 2018; 41: 355-366
9
Gagnebin Y,
Julien B,
Belén P.
et al.
Metabolomics in chronic kidney disease: Strategies for extended metabolome
coverage. J Pharmaceut Biomed Anal 2018; 161: 313-325
10
Alwashih MA,
Watson DG,
Andrew R.
et al.
Plasma metabolomic profile varies with glucocorticoid dose in patients with
congenital adrenal hyperplasia. Sci Rep 2017; 7: 17092
11
Claahsen van der Grinten HL,
Speiser PW,
Ahmed SF.
et al.
Congenital adrenal hyperplasia - current insights in pathophysiology,
diagnostics and management. Endocr Rev 2021; 43: 91-159
12
Navardauskaite R,
Semeniene K,
Sukys M.
et al.
Cardiometabolic health in adolescents and young adults with congenital adrenal
hyperplasia. Medicina 2022; 58: 500
13
Kamrath C,
Hartmann MF,
Pons-Kühnemann J.
et al.
Urinary GC–MS steroid metabotyping in treated children with congenital adrenal
hyperplasia. Metabolism 2020; 112: 154354
14
Nguyen LS,
Prifti E,
Ichou F.
et al.
Effect of congenital adrenal hyperplasia treated by glucocorticoids on plasma
metabolome: a machine-learning-based analysis. Sci Rep 2020; 10: 8859
15
Georgiev KD,
Radeva-Ilieva M,
Stoeva S.
et al.
Isolation, analysis and in vitro assessment of CYP3A4 inhibition by
methylxanthines extracted from Pu-erh and Bancha tea leaves. Sci Rep 2019; 9: 13941
16
Vrzal R,
Stejskalova L,
Monostory K.
et al.
Dexamethasone controls aryl hydrocarbon receptor (AhR)-mediated CYP1A1 and
CYP1A2 expression and activity in primary cultures of human hepatocytes. Chem Biol Interact 2008; 179: 288-296
17
Soo JY,
Wiese MD,
Dyson RM.
et al.
Methamphetamine administration increases hepatic CYP1A2 but not CYP3A activity
in female guinea pigs. Plos One 2020; 15: e0233010
18
Satoh N,
Nakamura M,
Suzuki A.
et al.
Effects of nitric oxide on renal proximal tubular Na+ transport. BioMed Res Int 2017; 6871081
19
Lin Y,
Yang Z,
Li J.
et al.
Effects of glutamate and aspartate on prostate cancer and breast cancer: a
Mendelian randomization study. BMC Genomics 2022; 23: 1-12
20
Li B,
Wang J,
Liao J.
et al.
YY1 promotes pancreatic cancer cell proliferation by enhancing mitochondrial
respiration. Cancer Cell Int 2022; 22: 287
21
Holeček M.
Roles of malate and aspartate in gluconeogenesis in various physiological and
pathological states. Metabolism 2023; 145: 155614
22
Harrison SA,
Webb WL,
Rammu H.
et al.
Prebiotic synthesis of aspartate using life’s metabolism as a guide. Life 2023; 13: 1177
23
Rumping L,
Vringer E,
Houwen RHJ.
et al.
Inborn errors of enzymes in glutamate metabolism. J Inherit Metab Dis 2019; 43: 200-215
24
Qi M,
Wang J,
Tan BE.
et al.
Dietary glutamine, glutamate, and aspartate supplementation improves hepatic
lipid metabolism in post-weaning piglets. Anim Nutr 2020; 6: 124-129
25
Jin J,
Byun J-K,
Choi Y-K.
et al.
Targeting glutamine metabolism as a therapeutic strategy for cancer. Exp Mol Med 2023; 55: 706-715
26
Bai L,
Bernard K,
Tang X.
et al.
Glutaminolysis epigenetically regulates antiapoptotic gene expression in
idiopathic pulmonary fibrosis fibroblasts. Am J Respir Cell Mol Biol 2019; 60: 49-57
27
Jankowska-Kulawy A,
Klimaszewska-Łata J,
Gul-Hinc S.
et al.
Metabolic and cellular compartments of acetyl-CoA in the healthy and diseased
brain. Int J Mol Sci 2022; 23: 10073
28
Ying M,
Guo C,
Hu X.
The quantitative relationship between isotopic and net contributions of lactate
and glucose to the tricarboxylic acid (TCA) cycle. J Biol Chem 2019; 294: 9615-9630
29
Manso G,
Baker AJ,
Taylor IK.
et al.
In vivo and in vitro effects of glucocorticosteroids on arachidonic acid
metabolism and monocyte function in nonasthmatic humans. Eur Respir J 1992; 5: 712-716
30
de Kloet AD,
Herman JP.
Fat-brain connections: Adipocyte glucocorticoid control of stress and
metabolism. Front Neuroendocrin 2018; 48: 50-57
31
Kuo T,
Chen T-C,
Lee RA.
et al.
Pik3r1 is required for glucocorticoid-induced perilipin 1 phosphorylation in
lipid droplet for adipocyte lipolysis. Diabetes 2017; 66: 1601-1610
32
Stimson RH,
Anderson AJ,
Ramage LE.
et al.
Acute physiological effects of glucocorticoids on fuel metabolism in humans are
permissive but not direct. Diabetes Obes Metab 2017; 19: 883-891
33
Ren X,
Shao Z,
Fan W.
et al.
Untargeted metabolomics reveals the effect of lovastatin on steroid-induced
necrosis of the femoral head in rabbits. J. Orthop Surg Res 2020; 15: 1-14
34
Poggiogalle E,
Jamshed H,
Peterson CM.
Circadian regulation of glucose, lipid, and energy metabolism in humans. Metabolism 2018; 84: 11-27
Comments (0)